Chinese Patent Medicine Industry: Global Market Opportunities and Forecast 2021-2027
Report Code: KNJ1014717
Publisher: Date of Publish:
No. of Pages: 167 Category: Pharmaceuticals and Healthcare Publisher: Date of Publish:
This report provides a comprehensive analysis of current global Chinese Patent Medicine market based on segmented types and downstream applications. Major product development trends are discussed under major downstream segment scenario. This report also focuses on major driving factors and inhibitors that affect the market and competitive landscape. Global and regional leading players in the Chinese Patent Medicine industry are profiled in a detailed way, with sales data and market share info. This report also includes global and regional market size and forecast, drill-down to top 20 economies. According to this survey, the global Chinese Patent Medicine market is estimated to have reached $ million in 2020, and projected to grow at a CAGR of % to $ million by 2027. Covid-19 pandemic has impacted the supply and demand status for many industries along the supply chain. Global Chinese Patent Medicine Market Status and Forecast 2021-2027 report makes a brilliant attempt to unveil key opportunities available in the global Chinese Patent Medicine market under the covid-19 impact to help readers in achieving a better market position. No matter the client is industry insider, potential entrant or investor, the report will provide useful data and information. The Global Chinese Patent Medicine Market has been exhibited in detail in the following chapters Chapter 1 displays the basic product introduction and market overview. Chapter 2 provides the competition landscape of global Chinese Patent Medicine industry. Chapter 3 provides the market analysis by type and by region Chapter 4 provides the market analysis by application and by region Chapter 5-10 presents regional and country market size and forecast, under the context of market drivers and inhibitors analysis. Chapter 11 analyses the supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis. Chapter 12 provides the market forecast by type and by application Chapter 13 provides the market forecast by region Chapter 14 profiles global leading players with their revenue, market share, profit margin, major product portfolio and SWOT analysis. Chapter 15 conclusions Segmented by Type Syrup Liquid Segmented by Application Online Sales Offline Sales Segmented by Country North America United States Canada Mexico Europe Germany France UK Italy Russia Spain Asia Pacific China Japan Korea Southeast Asia India Australasia Central & South America Brazil Argentina Colombia Middle East & Africa Iran Israel Turkey South Africa Saudi Arabia Key manufacturers included in this survey Taiji Group Co., Ltd. Shijiazhuang Pharmaceutical Group Co., Ltd. Shanghai Pharmaceutical (Group) Co., Ltd. Northeast Pharmaceutical Group Co., Ltd. North China Pharmaceutical Group Co., Ltd. Nanjing Pharmaceutical Industry (Group) Co., Ltd. Nanjing Pharmaceutical Co., Ltd Jiangxi Pharmaceutical Group Corporation Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. Harbin Pharmaceutical Group Co., Ltd Hangzhou Huadong Pharmaceutical Group Co., Ltd. Guangzhou Pharmaceutical Group Co., Ltd. Chongqing Pharmaceutical Co., Ltd China Pharmaceutical Group Corporation
Table of Contents 1 Product Introduction and Overview 1.1 Product Definition 1.2 Product Specification 1.3 Global Market Overview 1.3.1 Global Chinese Patent Medicine Market Status and Forecast (2016-2027) 1.3.2 Global Chinese Patent Medicine Sales Value CAGR by Region 1.4 Market Drivers, Inhibitors 1.4.1 Market Drivers 1.4.2 Market Inhibitors 1.4.3 COVID-19 Impact Analysis 2 Global Chinese Patent Medicine Supply by Company 2.1 Global Chinese Patent Medicine Sales Volume by Company 2.2 Global Chinese Patent Medicine Sales Value by Company 2.3 Global Chinese Patent Medicine Price by Company 2.4 Chinese Patent Medicine Production Location and Sales Area of Main Manufacturers 2.5 Trend of Concentration Rate 3 Global and Regional Chinese Patent Medicine Market Status by Type 3.1 Chinese Patent Medicine Type Introduction 3.1.1 Syrup 3.1.2 Liquid 3.1.3 Tablet 3.1.4 Others 3.2 Global Chinese Patent Medicine Market by Type 3.2.1 Global Chinese Patent Medicine Sales Volume by Type (2016-2021) 3.2.2 Global Chinese Patent Medicine Sales Value by Type (2016-2021) 3.2.3 Global Chinese Patent Medicine Price by Type (2016-2021) 3.3 North America: by Type 3.4 Europe: by Type 3.5 Asia Pacific: by Type 3.6 Central & South America: by Type 3.7 Middle East & Africa: by Type 4 Global and Regional Chinese Patent Medicine Market Status by Application 4.1 Chinese Patent Medicine Segment by Application 4.1.1 Online Sales 4.1.2 Offline Sales 4.2 Global Chinese Patent Medicine Market by Application 4.2.1 Global Chinese Patent Medicine Sales Volume by Application (2016-2021) 4.2.2 Global Chinese Patent Medicine Sales Value by Application (2016-2021) 4.2.3 Global Chinese Patent Medicine Price by Application (2016-2021) 4.3 North America: by Application 4.4 Europe: by Application 4.5 Asia Pacific: by Application 4.6 Central & South America: by Application 4.7 Middle East & Africa: by Application 5 Global Chinese Patent Medicine Market Status by Region 5.1 Global Chinese Patent Medicine Market by Region 5.1.1 Global Chinese Patent Medicine Sales Volume by Region 5.1.2 Global Chinese Patent Medicine Sales Value by Region 5.2 North America Chinese Patent Medicine Market Status 5.3 Europe Chinese Patent Medicine Market Status 5.4 Asia Pacific Chinese Patent Medicine Market Status 5.5 Central & South America Chinese Patent Medicine Market Status 5.6 Middle East & Africa Chinese Patent Medicine Market Status 6 North America Chinese Patent Medicine Market Status 6.1 North America Chinese Patent Medicine Market by Country 6.1.1 North America Chinese Patent Medicine Sales Volume by Country (2016-2021) 6.1.2 North America Chinese Patent Medicine Sales Value by Country (2016-2021) 6.2 United States 6.3 Canada 6.4 Mexico 7 Europe Chinese Patent Medicine Market Status 7.1 Europe Chinese Patent Medicine Market by Country 7.1.1 Europe Chinese Patent Medicine Sales Volume by Country (2016-2021) 7.1.2 Europe Chinese Patent Medicine Sales Value by Country (2016-2021) 7.2 Germany 7.3 France 7.4 UK 7.5 Italy 7.6 Russia 7.7 Spain 8 Asia Pacific Chinese Patent Medicine Market Status 8.1 Asia Pacific Chinese Patent Medicine Market by Country 8.1.1 Asia Pacific Chinese Patent Medicine Sales Volume by Country (2016-2021) 8.1.2 Asia Pacific Chinese Patent Medicine Sales Value by Country (2016-2021) 8.2 China 8.3 Japan 8.4 Korea 8.5 Southeast Asia 8.6 India 8.7 Australasia 9 Central & South America Chinese Patent Medicine Market Status 9.1 Central & South America Chinese Patent Medicine Market by Country 9.1.1 Central & South America Chinese Patent Medicine Sales Volume by Country (2016-2021) 9.1.2 Central & South America Chinese Patent Medicine Sales Value by Country (2016-2021) 9.2 Brazil 9.3 Argentina 9.4 Colombia 10 Middle East & Africa Chinese Patent Medicine Market Status 10.1 Middle East & Africa Chinese Patent Medicine Market by Country 10.1.1 Middle East & Africa Chinese Patent Medicine Sales Volume by Country (2016-2021) 10.1.2 Middle East & Africa Chinese Patent Medicine Sales Value by Country (2016-2021) 10.2 Iran 10.3 Israel 10.4 Turkey 10.5 South Africa 10.8 Saudi Arabia 11 Supply Chain and Manufacturing Cost Analysis 11.1 Supply Chain Analysis 11.2 Production Process Chart Analysis 11.3 Raw Materials and Key Suppliers Analysis 11.3.1 Raw Materials Introduction 11.3.2 Raw Materials Key Suppliers List 11.4 Chinese Patent Medicine Manufacturing Cost Analysis 11.5 Chinese Patent Medicine Sales Channel and Distributors Analysis 11.5.1 Chinese Patent Medicine Sales Channel 11.5.2 Chinese Patent Medicine Distributors 11.6 Chinese Patent Medicine Downstream Major Buyers 12 Global Chinese Patent Medicine Market Forecast by Type and by Application 12.1 Global Chinese Patent Medicine Sales Volume and Sales Value Forecast (2022-2027) 12.2 Global Chinese Patent Medicine Forecast by Type 12.2.1 Global Chinese Patent Medicine Sales Volume Forecast by Type 12.2.2 Global Chinese Patent Medicine Sales Value Forecast by Type 12.2.3 Global Chinese Patent Medicine Price Forecast by Type 12.3 Global Chinese Patent Medicine Forecast by Application 12.3.1 Global Chinese Patent Medicine Sales Volume Forecast by Application 12.3.2 Global Chinese Patent Medicine Sales Value Forecast by Application 12.3.3 Global Chinese Patent Medicine Price Forecast by Application 13 Global Chinese Patent Medicine Market Forecast by Region/Country 13.1 Global Chinese Patent Medicine Market Forecast by Region (2022-2027) 13.1.1 Global Chinese Patent Medicine Sales Volume Forecast by Region (2022-2027) 13.1.2 Global Chinese Patent Medicine Sales Value Forecast by Region (2022-2027) 13.2 North America Market Forecast 13.3 Europe Market Forecast 13.4 Asia Pacific Market Forecast 13.5 Central & South America Market Forecast 13.6 Middle East & Africa Market Forecast 14 Key Participants Company Information 14.1 Xinhualu Anti-Pharmaceutical Group Co., Ltd. 14.1.1 Company Information 14.1.2 Chinese Patent Medicine Product Introduction 14.1.3 Xinhualu Anti-Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.1.4 SWOT Analysis 14.2 Tianjin Pharmaceutical Group Co., Ltd. 14.2.1 Company Information 14.2.2 Chinese Patent Medicine Product Introduction 14.2.3 Tianjin Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.2.4 SWOT Analysis 14.3 Taiji Group Co., Ltd. 14.3.1 Company Information 14.3.2 Chinese Patent Medicine Product Introduction 14.3.3 Taiji Group Co., Ltd. Chinese Patent Medicine Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.3.4 SWOT Analysis 14.4 Shijiazhuang Pharmaceutical Group Co., Ltd. 14.4.1 Company Information 14.4.2 Chinese Patent Medicine Product Introduction 14.4.3 Shijiazhuang Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.4.4 SWOT Analysis 14.5 Shanghai Pharmaceutical (Group) Co., Ltd. 14.5.1 Company Information 14.5.2 Chinese Patent Medicine Product Introduction 14.5.3 Shanghai Pharmaceutical (Group) Co., Ltd. Chinese Patent Medicine Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.5.4 SWOT Analysis 14.6 Northeast Pharmaceutical Group Co., Ltd. 14.6.1 Company Information 14.6.2 Chinese Patent Medicine Product Introduction 14.6.3 Northeast Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.6.4 SWOT Analysis 14.7 North China Pharmaceutical Group Co., Ltd. 14.7.1 Company Information 14.7.2 Chinese Patent Medicine Product Introduction 14.7.3 North China Pharmaceutical Group Co., Ltd. Chinese Patent Medicine Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.7.4 SWOT Analysis 14.8 Nanjing Pharmaceutical Industry (Group) Co., Ltd. 14.8.1 Company Information 14.8.2 Chinese Patent Medicine Product Introduction 14.8.3 Nanjing Pharmaceutical Industry (Group) Co., Ltd. Chinese Patent Medicine Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.8.4 SWOT Analysis 14.9 Nanjing Pharmaceutical Co., Ltd 14.9.1 Company Information 14.9.2 Chinese Patent Medicine Product Introduction 14.9.3 Nanjing Pharmaceutical Co., Ltd Chinese Patent Medicine Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.9.4 SWOT Analysis 14.10 Jiangxi Pharmaceutical Group Corporation 14.10.1 Company Information 14.10.2 Chinese Patent Medicine Product Introduction 14.10.3 Jiangxi Pharmaceutical Group Corporation Chinese Patent Medicine Sales Volume, Price, Sales Value and Gross Margin (2019-2021) 14.10.4 SWOT Analysis 14.11 Jiangsu Yangzijiang Pharmaceutical Group Co., Ltd. 14.12 Harbin Pharmaceutical Group Co., Ltd 14.13 Hangzhou Huadong Pharmaceutical Group Co., Ltd. 14.14 Guangzhou Pharmaceutical Group Co., Ltd. 14.15 Chongqing Pharmaceutical Co., Ltd 14.16 China Pharmaceutical Group Corporation 15 Conclusion 16 Methodology
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com